HCA: Flat Base detected on 8 Jul 2026

HCA is forming a flat base consolidation pattern at $423.11, sandwiched between key support at $356.19 and resistance at $440.78. The structure score of 13/15 indicates well-defined price boundaries, though breakout (11/13) and volume (11/12) scores suggest moderate confirmation. RSI at 67.19 indicates rising momentum without overbought extremes. The overall 79/98 score and 64.99% win probability reflect a solid but not elite setup. Prior patterns (inverse head-and-shoulders on 5/11, symmetrical triangle on 5/27) provide historical context for this continuation structure.

HCA Healthcare has appreciated 17.17% over the past month and 7.85% in the past week, outperforming a challenging three-month period (-12.39%). The stock trades 23.71% below its 52-week high but 29.09% above its low, suggesting stabilization after recent volatility. The Health Care sector is in a bullish regime (0.83 score), supporting equity strength. HCA's low beta of 0.31 indicates defensive characteristics relative to market volatility. Volume remains subdued at 0.93x the 20-day average, suggesting consolidation before a directional move. Recent price strength alongside sector tailwinds and stabilized technicals align with accumulation into this base formation.

A successful breakout above $440.78 resistance would target the conservative measure of $441.44, representing a modest 0.43% move from resistance. More importantly, a decisive close above this level on above-average volume would confirm the base breakout. Invalidation occurs at $356.19 support; a close below this level would signal pattern failure and suggest consolidation exhaustion to the downside. The 64.99% win probability suggests roughly two-thirds of similar setups achieve directional resolution. Current ATR of 10.74 (2.54% of price) indicates expected daily volatility of approximately $10.74 per move.

RSI at 67.19 approaches overbought territory (>70), signaling potential near-term pullback before breakout confirmation. Volume ratio of 0.93 indicates below-average participation, reducing conviction in the consolidation structure—weak hands may capitulate prematurely. Healthcare sector valuations remain sensitive to policy changes, drug pricing legislation, and Medicare reimbursement rates. No specific near-term earnings or FDA catalyst dates are evident from current data, creating a vacuum that could allow drift or reversal. The low beta (0.31), while defensive, may limit upside capture if broader market rallies. Monitor for any sudden volume expansion accompanied by breaks below $420 support, which would signal early pattern failure before reaching key support at $356.19.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.